Medicinal plants from Nepal: Evaluation as inhibitors of leukotriene biosynthesis

Journal of Ethnopharmacology

Volumn 70, Issue 3, 2000, Pages 191-195

  Kumar, Sunil ^a   Ziereis, Klaus ^a   Wiegrebe, Wolfgang ^a   Müller, Klaus ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

5 Lipoxygenase; Antiinflammatory activity; Leukotrienes; Nepalese plants; Traditional medicine

Indexed keywords

LEUKOTRIENE; PLANT EXTRACT;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; IC 50; MEDICINAL PLANT; NEPAL; NONHUMAN; TRADITIONAL MEDICINE;

HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LEUKOTRIENES; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; NEPAL; NEUTROPHILS; PLANT EXTRACTS; PLANTS, MEDICINAL; SMOKE;

EID: 0034662471     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(00)00203-8     Document Type: Article

References (17)

1. Aehringhaus U., Peskar B.A., Wittenberg H.R., Wolbling R.H. Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis. British Journal of Pharmacology. 80:1983;73-80.
2. Asmawi M.Z., Kankaanranta H., Moilanen E., Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. Journal of Pharmacy and Pharmacology. 45:1993;581-584.
3. Borgeat P., Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proceedings of the National Academy of Sciences of the United States of America. 76:1979;2148-2152.
4. Drazen J.M., Austen K.F. Leukotrienes and airway responses. American Review of Respiratory Disease. 136:1987;985-998.
5. Ford-Hutchinson A.W. Evidence for the involvement of leukotrienes and other lipoxygenase products in disease states. Rokach J. Leukotrienes and Lipoxygenases. 1989;405-425 Elsevier, Amsterdam.
6. Henderson W.R. Jr Role of leukotrienes in asthma. Annals of Allergy. 72:1994;272-278.
7. Lenfeld J., Kroutil M., Marsálek E., Slavík J., Preininger V., Simánek V. Antiinflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Medica. 43:1981;161-165.
8. Müller K. 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs. Archiv der Pharmazie. 327:1994;3-19.
9. Müller K., Gürster D., Piwek S., Wiegrebe W. Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase. Journal of Medicinal Chemistry. 36:1993;4099-4107.
10. Musser J.H., Kreft A.F. 5-Lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors. Journal of Medicinal Chemistry. 35:1992;2501-2524.
11. Reanmongkol W., Tohda M., Matsumoto K., Subhadhirasakul S., Takayama H., Sakai S., Watanabe H. Inhibitory effect of alkaloids extracted from the stem bark of Hunteria zeylanica on 5-lipoxygenase activity in vitro. Biological and Pharmaceutical Bulletin. 18:1995;910-912.
12. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 220:1983;568-575.
13. Suwal P.N. Medicinal Plants of Nepal. 1993;Department of Medicinal Plants, HMG, Ministry of Forest and Soil Conservation, Thapathali, Nepal.
14. 4 formation. Prostaglandins, Leukottrienes and Essential Fatty Acids. 50:1994;279-284.
15. Vavrecková C., Gawlik I., Müller K. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Medica. 61:1996;397-401.
16. Waller D.P. Methods in ethnopharmacology. Journal of Ethnopharmacology. 38:1993;189-195.
17. Wasserman M.A., Smith E.F., Underwood D.C., Barnette M.A. Pharmacology and pathophysiology of 5-lipoxygenase products. Cooke S.T., Wong A. Lipoxygenases and Their Products. 1991;1-50 Academic Press, London.